Comments
Shares of Glenmark Pharmaceuticals today climbed 6 per cent after the company reported 20 per cent increase in consolidated net profit for the second quarter ended September 30, 2015.
The stock gained 5.96 per cent to Rs 1,000 on the BSE. On NSE, it rose 6 per cent to Rs 999.80.
Glenmark had yesterday reported 19.81 per cent increase in consolidated net profit to Rs 197.78 crore for the second quarter ended September 30, driven by good growth in India, US and Europe.
The company had posted a consolidated net profit of Rs 165.07 crore in the July-September quarter of the last fiscal, 2014-15, Glenmark had said in statement.
For the second quarter, consolidated revenue was at Rs 1,909.36 crore against Rs 1,680.70 crore, up 13.60 per cent, it said.
In the US, the company said its revenue from sale of finished dosage formulations was at Rs 598.4 crore compared with Rs 507.55 crore in the same quarter last fiscal, up 17.90 per cent.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.